Intravenous immunoglobulin for infectious diseases: Back to the pre-antibiotic and passive prophylaxis era?

Jagadeesh Bayry, Sébastien Lacroix-Desmazes, Michel D. Kazatchkine, Srini V. Kaveri

Результат исследований: Материалы для журналаСтатья

72 Цитирования (Scopus)

Аннотация

The dramatic increase in both the number of novel infectious agents and resistance to antimicrobial drugs has incited the need for adjunct therapies in the war against infectious diseases. Exciting recent studies have demonstrated the use of antibodies in the form of intravenous immunoglobulin (IVIg) against infections. By virtue of the diverse repertoire of immunoglobulins that possess a wide spectrum of antibacterial and antiviral specificities, IVIg provides antimicrobial efficacy independently of pathogen resistance and represents a promising alternative strategy for the treatment of diseases for which a specific therapy is not yet available.
Язык оригиналаАнглийский
ЖурналTrends in Pharmacological Sciences
Том25
Номер выпуска6
DOI
СостояниеОпубликовано - 1 янв 2004

Fingerprint Подробные сведения о темах исследования «Intravenous immunoglobulin for infectious diseases: Back to the pre-antibiotic and passive prophylaxis era?». Вместе они формируют уникальный семантический отпечаток (fingerprint).

  • Цитировать